Wedbush Starts NuPathe (PATH) at Outperform; Novel Drug Delivery for Better Patient Compliance
Tweet
Share
E-mailGet Alerts PATH Hot Sheet
Price: $16.01 --0%
Rating Summary:
8 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Rating Summary:
8 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 16
Join SI Premium – FREE
Wedbush initiates coverage on NuPathe (NASDAQ: PATH) with an Outperform. PT $20.00.
Wedbush analyst says, "NuPathe is an emerging pharmaceutical company applying proprietary drug delivery technologies to improve patient compliance. The company’s lead candidate, Zelrix, is a proprietary patch delivery of sumatriptan for acute migraine treatment. The company is targeting patients with gastrointestinal symptoms of nausea and vomiting who have difficulty completely swallowing an oral medication...In our view, PATH is undervalued at about $7 per share compared with our fair value of about $20."
For more ratings news on NuPathe click here and for the rating history of NuPathe click here.
Shares of NuPathe closed at $7.06 yesterday.
Wedbush analyst says, "NuPathe is an emerging pharmaceutical company applying proprietary drug delivery technologies to improve patient compliance. The company’s lead candidate, Zelrix, is a proprietary patch delivery of sumatriptan for acute migraine treatment. The company is targeting patients with gastrointestinal symptoms of nausea and vomiting who have difficulty completely swallowing an oral medication...In our view, PATH is undervalued at about $7 per share compared with our fair value of about $20."
For more ratings news on NuPathe click here and for the rating history of NuPathe click here.
Shares of NuPathe closed at $7.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Morgan Stanley Starts Target Hospitality (TH) at Overweight
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
